DOCS
Doximity, Inc.
$27.79
-0.79
(-2.76%)
Mkt Cap
5.20B
Volume
2,309,774
52W Range
17.15-73.92
Sector
Healthcare
Beta
1.22
EPS (TTM)
0.89 USD
P/E Ratio
31.22
Revenue (TTM)
655.57M USD
Rev Growth (5Y)
+25.5%
EPS Growth (5Y)
+54.3%
AlphaVal · Fair Value
What we estimate one share is worth
$26.10
Overvalued
weak signal
6.5% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
A-
Platform & Compounding FCF
86.9 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.
Company Description
Doximity, Inc. provides a digital platform, hosted in the cloud, specifically designed for healthcare practitioners throughout the United States. This platform delivers a suite of specialized tools, empowering its members to connect with peers, streamline patient treatment, conduct remote consultations, access current medical information and research, and advance their professional careers. Its primary clientele consists of pharmaceutical companies and healthcare organizations. Established in 2010, the entity initially operated as 3MD Communications, Inc. before rebranding to Doximity, Inc. in June of that year. The company's corporate headquarters are situated in San Francisco, California.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 644.86M | 570.40M | 475.42M | 419.05M | 343.55M | 206.90M | 116.39M | 85.69M |
| Net Income | 196.05M | 223.19M | 147.58M | 112.82M | 154.78M | 50.21M | 29.74M | 7.83M |
| EPS | 1.05 | 1.19 | 0.78 | 0.58 | 0.81 | 0.12 | 0.06 | 0.00 |
| Free Cash Flow | 317.50M | 266.74M | 178.29M | 173.42M | 120.88M | 78.36M | 21.95M | 14.12M |
| FCF / Share | 1.70 | 1.43 | 0.94 | 0.90 | 0.74 | 0.44 | 0.12 | 0.08 |
| Operating CF | 326.46M | 273.26M | 184.10M | 179.60M | 126.58M | 82.97M | 26.20M | 15.31M |
| Total Assets | 1.12B | 1.26B | 1.08B | 1.14B | 991.36M | 251.72M | 138.92M | 86.56M |
| Total Debt | 10.19M | 12.40M | 14.55M | 15.64M | 1.09M | 1.25M | 2.28M | 0 |
| Cash & Equiv | 219.18M | 209.61M | 96.78M | 158.03M | 112.81M | 66.39M | 48.43M | 33.61M |
| Book Value | 950.84M | 1.08B | 901.40M | 966.12M | 878.59M | 66.74M | 1.14M | 48.50M |
| Return on Equity | 0.21 | 0.21 | 0.16 | 0.12 | 0.18 | 0.75 | 26.18 | 0.16 |
| Metric | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 156.62M | 145.37M | 185.05M | 168.53M | 145.91M | 138.29M | 168.60M | 136.83M | 126.68M | 118.06M | 135.28M | 113.61M |
| Net Income | 24.32M | 19.11M | 61.56M | 62.06M | 53.32M | 62.46M | 75.20M | 44.15M | 41.38M | 40.62M | 47.96M | 30.60M |
| EPS | 0.13 | 0.10 | 0.33 | 0.33 | 0.28 | 0.33 | 0.40 | 0.24 | 0.22 | 0.22 | 0.26 | 0.16 |
| Free Cash Flow | 41.92M | 107.27M | 58.52M | 91.58M | 60.13M | 96.98M | 63.42M | 66.80M | 39.54M | 62.31M | 48.73M | 11.62M |
| FCF / Share | 0.23 | 0.58 | 0.31 | 0.46 | 0.32 | 0.51 | 0.34 | 0.36 | 0.21 | 0.33 | 0.26 | 0.06 |
| Operating CF | 41.99M | 109.52M | 60.89M | 93.94M | 62.10M | 98.49M | 65.19M | 68.35M | 41.24M | 63.94M | 50.05M | 12.90M |
| Total Assets | 1.08B | 1.12B | 1.16B | 1.26B | 1.20B | 1.26B | 1.17B | 1.12B | 1.07B | 1.08B | 1.00B | 1.03B |
| Total Debt | 9.67M | 10.19M | 10.69M | 11.27M | 11.84M | 12.40M | 12.95M | 13.49M | 14.03M | 14.55M | 15.06M | 15.05M |
| Cash & Equiv | 273.60M | 219.18M | 64.84M | 169.25M | 137.26M | 209.61M | 165.27M | 184.25M | 111.44M | 96.78M | 123.09M | 108.40M |
| Book Value | 916.07M | 950.84M | 979.30M | 1.10B | 1.03B | 1.08B | 1.03B | 961.20M | 913.58M | 901.40M | 864.61M | 871.47M |
| Return on Equity | 0.03 | 0.02 | 0.06 | 0.06 | 0.05 | 0.06 | 0.07 | 0.05 | 0.05 | 0.05 | 0.06 | 0.04 |
DOCS News
Kaplan Fox Advises Doximity, Inc. (DOCS) Investors to Act Before the Lead Plaintiff Deadline on November 16, 2026
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS
DOCS Shareholder Alert: November 16, 2026 Lead Plaintiff Deadline in Doximity, Inc. Securities Class Action - Contact SueWallSt
DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Doximity, Inc. (DOCS)
ROSEN, A LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
Deadline Alert: Doximity, Inc. (DOCS) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Reasons to Retain Doximity Stock in Your Portfolio for Now
DOCS INVESTOR NOTICE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces - November 16, 2026 Deadline